<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Process" Owner="NLM">        <PMID Version="1">30290775</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>16</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">1471-2407</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>18</Volume>                    <Issue>1</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>05</Day>                    </PubDate>                </JournalIssue>                <Title>BMC cancer</Title>                <ISOAbbreviation>BMC Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer.</ArticleTitle>            <Pagination>                <MedlinePgn>958</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12885-018-4869-5</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Paclitaxel induced peripheral neuropathy (PIPN) is a major debilitating side effect of paclitaxel in patients with breast cancer with no fully known mechanisms. The aim of the study was to find out the possible risk factors for PIPN.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">Eligible patients with node positive breast cancer undergoing chemotherapy with paclitaxel were assessed. They belonged to an initial randomized controlled trial in which the effectiveness of omega-3 fatty acids in preventing and reducing severity of PIPN was evaluated (protocol ID: NCT01049295). Reduced total neuropathy score (r-TNS) was used for measuring PIPN. All analyses were performed adjusting for intervention effect. The association between age, BMI, BSA, pathological grade, molecular biomarkers and PIPN was evaluated.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty-seven patients with breast cancer were investigated. Age was significantly associated with risk of PIPN (RR:1.50, P value = .024). Body mass index and BSA had significant association with severity of PIPN (B:1.28, P = .025; and B: 3.88, P = .010 respectively). Also, BSA showed a significant association with the risk of PIPN (RR: 2.28, P = .035; B: 3.88, P = .035). Incidence and severity of PIPN were much more pronounced in progesterone receptor positive (PR<sup>+</sup>) patients (RR:1.88, P = .015 and B:1.54, P = .012). Multivariate analysis showed that age and the status of PR<sup>+</sup> were independent risk factor for incidence and the status of PR<sup>+</sup> was the only independent risk factor for severity of PIPN.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Age, BSA and the status of PR<sup>+</sup>, should be considered as the risk factors for PIPN before commencement of chemotherapy with paclitaxel in patients with breast cancer. Older patients, those with greater BSA and PR<sup>+</sup> patients may need closer follow up and more medical attention due to greater incidence and severity of PIPN.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Ghoreishi</LastName>                    <ForeName>Zohreh</ForeName>                    <Initials>Z</Initials>                    <AffiliationInfo>                        <Affiliation>Nutrition Research Center, Department of Clinical Nutrition, School of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Keshavarz</LastName>                    <ForeName>Seyedali</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Asghari Jafarabadi</LastName>                    <ForeName>Mohammad</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Road Traffic Injury Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fathifar</LastName>                    <ForeName>Zahra</ForeName>                    <Initials>Z</Initials>                    <AffiliationInfo>                        <Affiliation>School of Health, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Goodman</LastName>                    <ForeName>Karyn A</ForeName>                    <Initials>KA</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, School of Medicine, University of Colorado, Aurora, CO, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Esfahani</LastName>                    <ForeName>Ali</ForeName>                    <Initials>A</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-5278-3049</Identifier>                    <AffiliationInfo>                        <Affiliation>Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Shahid Ghazi Hospital, Tabriz, Iran. ali.sfhn@gmail.com.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>9683</GrantID>                    <Agency>Tehran University of Medical Sciences</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>05</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>BMC Cancer</MedlineTA>            <NlmUniqueID>100967800</NlmUniqueID>            <ISSNLinking>1471-2407</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2014 Feb;25(2):493-9</RefSource>                <PMID Version="1">24478323</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ginekol Pol. 2016;87(7):516-21</RefSource>                <PMID Version="1">27504945</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pharmacol Ther. 2007 Oct;116(1):77-106</RefSource>                <PMID Version="1">17659348</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Peripher Nerv Syst. 2000 Dec;5(4):191-208</RefSource>                <PMID Version="1">11151980</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 1998 Nov 18;280(19):1690-1</RefSource>                <PMID Version="1">9832001</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Pain Headache Rep. 2006 Aug;10(4):279-87</RefSource>                <PMID Version="1">16834943</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gynecol Oncol. 2015 Feb;136(2):323-7</RefSource>                <PMID Version="1">25529832</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. 2015;16(17):7603-6</RefSource>                <PMID Version="1">26625769</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Muscle Nerve. 2013 Oct;48(4):507-15</RefSource>                <PMID Version="1">23424094</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Muscle Nerve. 2005 Sep;32(3):360-3</RefSource>                <PMID Version="1">15880630</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2005 Jan 27;352(4):341-50</RefSource>                <PMID Version="1">15673800</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Support Care Cancer. 2012 Oct;20(10):2433-9</RefSource>                <PMID Version="1">22231480</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Peripher Nerv Syst. 2009 Mar;14(1):36-44</RefSource>                <PMID Version="1">19335538</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Blood. 2008 Sep 1;112(5):1593-9</RefSource>                <PMID Version="1">18574024</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2012 Apr 15;118(8 Suppl):2207-16</RefSource>                <PMID Version="1">22488695</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2012 Aug 15;12:355</RefSource>                <PMID Version="1">22894640</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Int Med Res. 2011;39(2):366-77</RefSource>                <PMID Version="1">21672340</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer. 2004;11(1):92-9</RefSource>                <PMID Version="1">14718800</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Clin Oncol. 2013 Aug;36(4):331-7</RefSource>                <PMID Version="1">22547012</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Support Care Cancer. 1999 Sep;7(5):354-61</RefSource>                <PMID Version="1">10483822</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Res. 2010 Feb;30(2):623-8</RefSource>                <PMID Version="1">20332480</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Health Psychol Res. 2013 Sep 23;1(3):e28</RefSource>                <PMID Version="1">26973913</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncology (Williston Park). 2016 Nov 15;30(11):1020-9</RefSource>                <PMID Version="1">27854104</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Horm Behav. 2013 Feb;63(2):284-90</RefSource>                <PMID Version="1">22732134</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2012 Mar;23(3):632-8</RefSource>                <PMID Version="1">21693770</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Res. 2013 Mar;33(3):1153-6</RefSource>                <PMID Version="1">23482795</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neurology. 2003 Nov 11;61(9):1297-300</RefSource>                <PMID Version="1">14610145</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Clin Oncol. 2013 Feb;18(1):132-8</RefSource>                <PMID Version="1">22105895</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sports Med. 2014 Sep;44(9):1289-304</RefSource>                <PMID Version="1">24927670</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="Y">Breast neoplasms</Keyword>            <Keyword MajorTopicYN="Y">Paclitaxel</Keyword>            <Keyword MajorTopicYN="Y">Peripheral nervous system diseases</Keyword>            <Keyword MajorTopicYN="Y">Receptors, progesterone</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>03</Month>                <Day>19</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>09</Month>                <Day>26</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30290775</ArticleId>            <ArticleId IdType="doi">10.1186/s12885-018-4869-5</ArticleId>            <ArticleId IdType="pii">10.1186/s12885-018-4869-5</ArticleId>            <ArticleId IdType="pmc">PMC6173931</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>